Dr Mark Lythgoe
@DrMarkLythgoe
Followers
551
Following
9K
Media
16
Statuses
966
Medical Oncology fellow & Pharmacist at @imperialcollege @ImperialSandC doing PhD in #cancer #microbiome -interest in health policy, drug development & @rovers
London, England
Joined December 2018
Delighted to share new article in @TheLancetOncol reviewing #UK post #Brexit #cancer drug approval pathways. Thanks to amazing authors @ravindhi @sarah_blagden @AggarwalOnc @SullivanProf . Thanks for input @PORTAL_Research @akesselheim . @ImperialSandC .
3
14
42
RT @CF_PC_OvCaGroup: Massive congratulations our fantastic Clinical Research Fellow Dr James Clark on passing his PhD viva this afternoon!!….
0
2
0
RT @ADesaiMD: 🚨Our RWE #perioperative #NSCLC study now in @JAMANetworkOpen study of 1334 pts with stage II–IIIA resectable NSCLC:.◼️Neoadj….
0
26
0
Simple things work best in #clinical #trial recruitment - single page recruitment letter………….though no preference in different colours! . @pash22 @ECMC_UK @sarah_blagden .
0
2
10
RT @DavidBenjaminMD: Thank you @CancerTodayMag @AACR for featuring our recent @myESMO Real World Data & Digital Oncology study on the portr….
0
4
0
RT @pash22: @DrMarkLythgoe @DrSidMukherjee @NewYorker @NHSuk @SullivanProf @oncology_bg @EricTopol @sarah_blagden Yup, already tweeted that….
0
1
0
Excellent article 'The Catch in Catching Cancer Early' from @DrSidMukherjee in the @NewYorker discussing the promise of #early #cancer #detection and the experience with #GRAIL in @NHSuk . @SullivanProf @oncology_bg @pash22 @EricTopol @sarah_blagden.
3
7
15
RT @kjmeetswrld: 💡New in JCP with @ariadna_tibau @akesselheim . We find the time for @US_FDA oncology indications to achieve conversion to….
0
3
0
RT @SullivanProf: Outstanding work by Chris Booth and colleagues - major impact - and showing just what non pharmaceutical interventions ca….
0
22
0
RT @oncology_bg: Honoured to be inducted as a fellow of the American Society of Clinical Oncology at the opening ceremony yesterday. Thank….
0
8
0
RT @darioT_: An incredible dr #Leone @LaStatale presenting on patterns of inclusion & persisting barriers for access in clinical trials 4 p….
0
6
0
RT @pash22: Reading and Interpreting Quality-of-Life Results in Cancer Trials.via @MassimoDiMaio75 @Maherjane @DrMa….
0
2
0
RT @kjmeetswrld: Several malignancies for which there are no medicines recommended on the EML, including stomach, liver, esophagus, thyroid….
0
5
0
RT @oncology_bg: Brand new paper just live in @BMJOncology . In this study, we evaluate if DFS can be a reliable surrogate for OS in early-….
0
6
0
Do we need to rationalise CT Scan in #medicine? . Study in @JAMAInternalMed suggests current CT usage could result in 1 in 20 of ALL cancers in the near-future. @pash22 @SullivanProf @SuyogCancer @oncodaily @oncology_bg @OncoAlert @OncBrothers
4
3
11
Great to see #subcutaneous #nivolumab approved in the #UK to enhance patient experience and access in lung, melanoma, kidney and many other cancer types. @CR_UK @focusonmelanoma @Roy_Castle_Lung @BTOGORG @DrSanjayPopat @tompowles1 @kidneycanceruk .
2
6
12
RT @andrewgregory: Exclusive: British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being d….
0
3
0
Not all PDL1 assays are the same in #bladder #cancer - important work. do we need to re-evaluate the clinical utility of how we measure PDL1 and does this have implications for other cancers???. @DavidBenjaminMD @tompowles1 @SuyogCancer @BladderCancerUK .
1
1
7
RT @pash22: Therapeutic Benefit of Top-Selling Oncology Drugs in US @MedicareGov.via @akesselheim et al @DrMarkLyth….
0
2
0
RT @DavidBenjaminMD: Is the field of oncology overlooking sexual health and reproductive toxicities from cancer therapies?. In @TheLancetOn….
0
9
0
🧨Great to be editors pick in @TheLancetOncol this month for our comment. highlighting Sexual health and reproductive toxicity from cancer therapies. @DavidBenjaminMD @ImperialSandC @pash22 @SullivanProf @oncology_bg @darioT_ @SuyogCancer @BMJOncology
1
5
23